# Benfotiamine in Alzheimer's Disease: A Pilot Study

> **NCT02292238** · PHASE2 · COMPLETED · sponsor: **Burke Medical Research Institute** · enrollment: 71 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Benfotiamine

## Key facts

- **NCT ID:** NCT02292238
- **Lead sponsor:** Burke Medical Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-15
- **Primary completion:** 2020-07-20
- **Final completion:** 2020-09-08
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2022-06-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02292238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02292238, "Benfotiamine in Alzheimer's Disease: A Pilot Study". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT02292238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*